![Joris Schuurmans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joris Schuurmans
Vorstandsvorsitzender bei Cergentis BV
Aktive Positionen von Joris Schuurmans
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Geschäftsführer | 01.06.2013 | - |
Cergentis BV
![]() Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Vorstandsvorsitzender | 01.06.2020 | - |
Karriereverlauf von Joris Schuurmans
Ehemalige bekannte Positionen von Joris Schuurmans
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCARTIS GROUP NV | Geschäftsführer | - | - |
Statistik
International
Schweiz | 2 |
Belgien | 2 |
Niederlande | 2 |
Operativ
Chief Operating Officer | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOCARTIS GROUP NV | Health Technology |
Private Unternehmen | 2 |
---|---|
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
Cergentis BV
![]() Cergentis BV Miscellaneous Commercial ServicesCommercial Services Part of Solvias AG, Cergentis BV is a Dutch genomics company that develops and commercializes TLA-based diagnostic kits for targeted complete next-generation sequencing of (trans) genes and gene editing events. The company is based in Utrecht, Netherlands. The company also provides commercial services for leading research institutes and pharmaceutical companies worldwide. The company was founded in 2012. Joris Schuurmans has been the CEO of the company since 2020. Cergentis was acquired by Solvias AG on July 12, 2022. | Commercial Services |
- Börse
- Insiders
- Joris Schuurmans
- Erfahrung